You just read:

Jiangsu Hengrui Medicine Enters into Agreement with The University of Texas MD Anderson Cancer Center to Advance Immunotherapy and Precision Medicine for Cancer Treatment

News provided by

Jiangsu Hengrui Medicine Co., Ltd

May 03, 2016, 08:09 ET